Definitive Contract 75F40125C00049
Award Date
8/27/25
Potential Completion Date
9/29/27
Potential Value
$288K
Federal Agency
Food and Drug Administration
Awardee
University Of Maryland Baltimore
Ultimate Awardee
Not listed
PSC Category
AJ11 - General Science And Technology R&D Services; General Science And Technology; Basic Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21201, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $669,734.24, was issued by the Food and Drug Administration (FDA) to the University of Maryland, Baltimore (UMB) to provide NONDESTRUCTIVE ANALYTICS FOR VACCINES. The contract is a definitive, firm fixed-price agreement, with a period of performance through March 29, 2024. UMB, the prime contractor, is a major public research university and the founding campus of the University System of Maryland (USM). The contract does not have a set-aside designation....
This is a $61,418 firm fixed price contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the University of Maryland, Baltimore (UMB) on July 29, 2020. The contract is for the manufacture of an in vitro component to evaluate generic and new animal drug formulations that are not systemically absorbed. The contract has no set-aside designation and is scheduled for completion on June 30, 2023. UMB is a medical research university that has...
This is a $29,057,109.85 definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) for biomedical research and development. The contract has no set-aside designation. UMB, a major public research university, is the prime contractor and frequently receives federal contracts and grants for its expertise in areas such as medicine, nursing,...
This is a $879,424.00 firm fixed-price service agreement contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to the University of Maryland, Baltimore (UMB) on February 28, 2017. The contract has a base year period of performance ending on February 28, 2020, with no set-aside designation. UMB is providing services under this contract, which is part of a larger $6 million Blanket Purchase Agreement with the Department of Veterans Affairs for reagents, supplies,...
This is a definitive federal contract awarded by the Department of Health and Human Services' National Institutes of Health to the University of Maryland, Baltimore (UMB) for an Adjuvant Development Program. The $7,110,426.96 contract has a period of performance through September 29, 2024 and uses a cost no fee pricing type. UMB is the prime contractor, and the contract is not set aside for any specific business category. The contract supports biomedical research and product development, with...
The University of Maryland, Baltimore has been awarded a federal contract by the Food and Drug Administration to generate highly curated whole genome sequences for bacterial pathogens from the FDA-CDC Antimicrobial Resistance Isolate Bank. The $199,985.00 definitive, firm fixed-price contract does not have a set-aside designation. The University of Maryland, Baltimore is the prime contractor and is a major public research university that frequently receives federal funding through contracts...
This is a $85,000 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to the University of Maryland, Baltimore (UMB). The contract has a base year period of performance ending on September 14, 2022 and was awarded on September 11, 2020 with no set-aside designation. UMB, which serves as the prime contractor, is a major public research university that frequently receives federal contract and grant awards to support its biomedical research,...
This is a $213,124.28 firm fixed price definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to the University of Maryland, Baltimore (UMB) for research services. The contract has a completion date of September 30, 2018 and was awarded on October 1, 2017. UMB is a state-controlled institution of higher learning that provides a range of research, healthcare, and education services to federal agencies, including the VA and Department of Health and...
This is a $114,280.66 firm fixed price research contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to the University of Maryland, Baltimore (UMB). The contract, which does not have a set-aside designation, was awarded on October 1, 2017 and is scheduled for completion on June 24, 2020. UMB, an academic institution and medical center, has experience providing a variety of research, healthcare, and education services to federal agencies, including the VA....
This is a $462,000.00 firm fixed price definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to the University of Maryland, Baltimore (UMB) on April 1, 2018. The contract, which does not have a set-aside designation, is for research services to be completed by March 31, 2023. UMB is a subunit of the University System of Maryland (USM), a state higher education system that also provides federal contract support services, including telecommunications...